These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16541121)

  • 1. Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
    Sakurai F; Kawabata K; Koizumi N; Inoue N; Okabe M; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2006 Jul; 13(14):1118-26. PubMed ID: 16541121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
    Sakurai F; Nakamura SI; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
    Gene Ther; 2009 Feb; 16(2):297-302. PubMed ID: 18800152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of human CD46 by adenovirus serotype 35 vectors.
    Sakurai F; Akitomo K; Kawabata K; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Jun; 14(11):912-9. PubMed ID: 17377598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.
    Ni S; Gaggar A; Di Paolo N; Li ZY; Liu Y; Strauss R; Sova P; Morihara J; Feng Q; Kiviat N; Touré P; Sow PS; Lieber A
    Cancer Gene Ther; 2006 Dec; 13(12):1072-81. PubMed ID: 16874361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
    Sakurai F; Mizuguchi H; Hayakawa T
    Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient gene delivery in human and rodent mast cells using adenovirus vectors.
    Nakashima K; Sakurai F; Kawabata K; Mizuguchi H
    J Control Release; 2008 Aug; 129(3):215-22. PubMed ID: 18572269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35.
    Sakurai F; Murakami S; Kawabata K; Okada N; Yamamoto A; Seya T; Hayakawa T; Mizuguchi H
    J Control Release; 2006 Jul; 113(3):271-8. PubMed ID: 16790289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates.
    Sakurai F; Nakamura S; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
    Mol Ther; 2008 Apr; 16(4):726-33. PubMed ID: 18362928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates].
    Sakurai F; Kawabata K; Mizuguchi H
    Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.
    Yu L; Takenobu H; Shimozato O; Kawamura K; Nimura Y; Seki N; Uzawa K; Tanzawa H; Shimada H; Ochiai T; Tagawa M
    Oncol Rep; 2005 Oct; 14(4):831-5. PubMed ID: 16142339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.
    Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH
    Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
    Suominen E; Toivonen R; Grenman R; Savontaus M
    J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
    Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
    J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transduction Properties of Adenovirus Serotype 35 Vectors After Intravenous Administration Into Nonhuman Primates.
    Sakurai F; Nakamura SI; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
    Mol Ther; 2008 Apr; 16(4):726-733. PubMed ID: 28178464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells.
    Murakami S; Sakurai F; Kawabata K; Okada N; Fujita T; Yamamoto A; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Nov; 14(21):1525-33. PubMed ID: 17805302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adenovirus type 35: nucleotide sequence and vector development.
    Gao W; Robbins PD; Gambotto A
    Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.